Coexistence of sensitive and resistant epidermal growth factor receptor (EGFR) mutations in pretreatment non-small cell lung cancer (NSCLC) patients: First or third generation tyrosine kinase inhibitors (TKIs)?

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Third Generation ◽

Small Cell Lung ◽

Epidermal Growth ◽

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

Clinical & Translational Oncology ◽

10.1007/s12094-011-0739-1 ◽

2011 ◽

Vol 13 (11) ◽

pp. 812-818 ◽

Cited By ~ 1

Author(s):

Elena María Martínez-Navarro ◽

Joseba Rebollo ◽

Ramón González-Manzano ◽

Manuel Sureda ◽

Elena Evgenyeva ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Response Rate ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(21)01977-8 ◽

2021 ◽

Vol 16 (4) ◽

pp. S770-S771

Author(s):

J. Subramanian ◽

Y-L. Choi ◽

T-Y. Chou ◽

J. Gregg ◽

R. Hui ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Advanced Stage ◽

Small Cell Lung ◽

Epidermal Growth ◽

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome

Annals of Oncology ◽

10.1093/annonc/mdx426.006 ◽

2017 ◽

Vol 28 ◽

pp. vi56

Author(s):

I. Stasi ◽

A. Farnesi ◽

E. Vasile ◽

I. Petrini ◽

M. Luccchesi ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Egfr Tkis

Prognostic Factors in Non-Small-Cell Lung Cancer (NSCLC) Patients with Epidermal Growth Factor Receptor (EGFR) Mutations: Data from the Randomized Phase III Study Compared Gefitinib with Carboplatin Plus Paclitaxel (NEJ002)

Annals of Oncology ◽

10.1016/s0923-7534(20)32317-6 ◽

2012 ◽

Vol 23 ◽

pp. xi116

Author(s):

Y. Minegishi ◽

K. Kobayashi ◽

M. Maemondo ◽

A. Inoue ◽

S. Sugawara ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Phase Iii ◽

Egfr Mutations ◽

Small Cell Lung ◽

Phase Iii Study ◽

Epidermal Growth ◽

The quantitatively analysis of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) and its correlation with response rate of EGFR tyrosine kinase inhibitors (TKI)

10.1158/diag-10-pr10 ◽

2010 ◽

Cited By ~ 1

Author(s):

Jun Li ◽

Zhao Chen ◽

Daqiang Sun ◽

Meilin Xu ◽

Xun Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Kinase Inhibitors ◽

Response Rate ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Epidermal Growth

Clinical Significance of Disease Flares in Patients with Non-small Cell Lung Cancer with Positive EGFR Mutations Following the Suspension of Treatment with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

Haigan ◽

10.2482/haigan.54.1 ◽

2014 ◽

Vol 54 (1) ◽

pp. 1-5 ◽

Cited By ~ 1

Author(s):

Ai Yamamoto ◽

Kazutoshi Isobe ◽

Kyohei Kaburaki ◽

Arisa Kinoshita ◽

Tomohiro Wada ◽

...

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase Inhibitors

Receptor Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Uncommon epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer and sensitivity to EGFR tyrosine kinase inhibitors, a two centers experience

Annals of Oncology ◽

10.1093/annonc/mdw332.20 ◽

2016 ◽

Vol 27 ◽

pp. iv9

Author(s):

M. Bonomi ◽

L. Bonomi ◽

M.G. Sauta ◽

A.C. Bettini ◽

M. Squadroni ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Egfr Tyrosine Kinase Inhibitors ◽

Epidermal Growth

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

Lung Cancer ◽

10.1016/j.lungcan.2014.02.011 ◽

2014 ◽

Vol 84 (2) ◽

pp. 161-167 ◽

Cited By ~ 50

Author(s):

Noemi Reguart ◽

Rafael Rosell ◽

Felipe Cardenal ◽

Andres F. Cardona ◽

Dolores Isla ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

9004 ORAL BRCA1 and Astrocyte Elevated Gene-1 (AEG-1) Expression and Outcome of Erlotinib-Treated Non-Small-Cell Lung Cancer (NSCLC) Patients (p) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations

European Journal of Cancer ◽

10.1016/s0959-8049(11)72316-4 ◽

2011 ◽

Vol 47 ◽

pp. S593

Author(s):

M. Taron ◽

S.B. Benlloch ◽

J.J.S. Sanchez ◽

R.R. Rosell ◽

C.C. Costa ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Egfr Mutations ◽

Small Cell Lung ◽

Epidermal Growth ◽

Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer

Frontiers in Oncology ◽

10.3389/fonc.2017.00113 ◽

2017 ◽

Vol 7 ◽

Cited By ~ 27

Author(s):

Tristan A. Barnes ◽

Grainne M. O’Kane ◽

Mark David Vincent ◽

Natasha B. Leighl

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Small Cell ◽

Third Generation ◽

Small Cell Lung ◽

Epidermal Growth